Hsin‐Kai Liao

In Vivo Target Gene Activation via CRISPR/Cas9-Mediated Trans-epigenetic Modulation

Hsin‐Kai Liao, Fumiyuki Hatanaka, Toshikazu Araoka et al. · Cell · 2017 · 441 citations · Full text

In Vivo Gene Therapy, Genetics, Genetic Engineering +7

Use of the CRISPR/Cas9 system as an intracellular defense against HIV-1 infection in human cells

Hsin‐Kai Liao, Ying Gu, Arturo Diaz et al. · Nature Communications · 2015 · 334 citations · Full text

Engineering, Hiv-targeted Crispr/cas9, Immunology +18

Targeted Gene Correction Minimally Impacts Whole-Genome Mutational Load in Human-Disease-Specific Induced Pluripotent Stem Cell Clones

Keiichiro Suzuki, Chang Yu, Jing Qu et al. · Cell stem cell · 2014 · 172 citations · Full text

Induced Pluripotent Stem Cell, Medicine, Genetics +9

Single-dose CRISPR–Cas9 therapy extends lifespan of mice with Hutchinson–Gilford progeria syndrome

Ergin Beyret, Hsin‐Kai Liao, Mako Yamamoto et al. · Nature Medicine · 2019 · 152 citations

Single-dose Crispr–cas9 Therapy, Natural Sciences, Immunology +8

In vivo partial cellular reprogramming enhances liver plasticity and regeneration

Tomoaki Hishida, Mako Yamamoto, Yuriko Hishida-Nozaki et al. · Cell Reports · 2022 · 97 citations · Full text